First Time Loading...

Silence Therapeutics PLC
NASDAQ:SLN

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
NASDAQ:SLN
Watchlist
Price: 21.3 USD -0.56%
Updated: May 3, 2024

Silence Therapeutics PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Silence Therapeutics PLC
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Silence Therapeutics PLC
NASDAQ:SLN
Revenue
£244k
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$27m
CAGR 3-Years
37%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
£673.1m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%

See Also

What is Silence Therapeutics PLC's Revenue?
Revenue
244k GBP

Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Revenue amounts to 244k GBP.

What is Silence Therapeutics PLC's Revenue growth rate?
Revenue CAGR 3Y
-32%

The average annual Revenue growth rates for Silence Therapeutics PLC have been -32% over the past three years .